Search for Clinical Trial Results

Sponsored By

Heart Septal Defects - 39 Studies Found

Status Study
Completed Study Name: Fluid Balance During Closure of Atrial Septal Defect
Condition:
  • Heart Defects,Congenital
  • Heart Septal Defects, Atrial
    • Date: 2012-12-21
Not yet recruiting Study Name: The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.
Condition: Ventricular Septal Defect
Date: 2016-09-20
Interventions:
  • Drug: Salbutamol Ventoline(R),
Not yet recruiting Study Name: Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study
Condition: Atrial Septal Defect
Date: 2008-03-31
Interventions: Device: AMPLATZER Septal Occluder AMPLATZER Septal Occluder
Completed Study Name: Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study
Condition: Ventricular Septal Defects
Date: 2008-03-27
Interventions: Device: Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder) Device
Enrolling by invitation Study Name: International Registry for ASD Closure by Using the Occlutech®Flex II Device in More Than 2000 Patients
Condition: Atrial Septal Defect
Date: 2016-05-05
Interventions: Device: ASD closure with the Occlutech Flex II ASD closure device Monitoring of possible device related
Completed Study Name: Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
Condition: Atrial Septal Defect
Date: 2016-11-28
Interventions: Device: GORE® CARDIOFORM ASD Occluder Percutaneous Atrial Septal Defect Closure
Completed Study Name: Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER
Condition: Membranous Ventricular Septal Defects
Date: 2007-12-20
Interventions: Device: AMPLATZER Membranous VSD Occluder Device closure with the AMPLATZER Membranous VSD Occluder
Completed Study Name: Bosentan for Mild Pulmonary Vascular Disease in Asd Patients.
Condition: Heart Septal Defects, Atrial
Date: 2010-10-08
Interventions:
  • Drug: Bosentan Treatment will

Completed Study Name: ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Condition: Atrial Septal Defect Secundum
Date: 2014-12-02
Interventions: Device: atrial septal occluder Single arm atrial septal defect closure with the AMPLATZER Septal Occlude
Completed Study Name: Hybrid Closure of Congenital Heart Disease
Condition: Pediatric Ventricular Septal Defects
Date: 2016-05-25
Interventions:
  • Drug: sufentanil anesthesia An
<<< Previous | Next >>>